勃林格殷格翰
Henri Doods received his PhD in Pharmacology at the University of Amsterdam. He joined Boehringer Ingelheim in 1987 and covered different positions within cardiovascular, pain, obesity, central nervous system and respiratory research. Currently, he heads the Global Department Research Beyond Borders with the responsibility to capture emerging science/new indications and novel technologies/modalities and is member of the Global Boehringer Ingelheim Discovery Research Leadership Committee. He is (co) author of more than 135 publications and was involved in progressing > 15 compounds into development.